Publisher
Springer Berlin Heidelberg
Reference35 articles.
1. Andersen M, Kristjansen PEG, Hansen H (1990) Second-line chemotherapy in small cell lung cancer. Cancer Treat Rev 17: 427–436
2. Ardizzoni A, Hansen H, Dombernowsky P et al. (1997) Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. J Clin Oncol 15: 2090–2096
3. Ardizzoni A, Antonelli G, Ricci S et al. (2000) Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap study. Am J Clin Oncol 23: 22–26
4. Ardizzoni A, Manegold C, Debruyne C et al. (2003) EORTC phase II study of topotecan in combination with cisplatin as secondline treatment of refractory and sensitive small-cell lung cancer. Clin Cancer Res 9: 143–150
5. Batist G, Ihde DC, Zabell A et al. (1983) Small cell carcinoma of the lung: reinduction chemotherapy after late relapse. Ann Intern Med 98: 472–474